Publications by authors named "Juerg Gasser"

Claim this Profile
C
Characterization of quinazolinone calcilytic therapy for autosomal dominant hypocalcemia type 1 (ADH1).
Fadil M Hannan, Kreepa G Kooblall, Mark Stevenson, Taha Elajnaf, Fangyu Liu, Juerg A Gasser

J Biol Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid.
Sonja Gamsjaeger, Birgit Buchinger, Elizabeth Zwettler, Robert Recker, Dennis Black, Juerg A Gasser

J Bone Miner Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function.
Anke Bentmann, Nina Kawelke, David Moss, Hanswalter Zentgraf, Yohann Bala, Juerg A Gasser

J Bone Miner Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Robert R Recker, Pierre D Delmas, Johan Halse, Ian R Reid, Steven Boonen, Juerg Gasser

J Bone Miner Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-induced structural joint damage is mediated by IL-1.
Jochen Zwerina, Kurt Redlich, Karin Polzer, Leo Joosten, Gerhard Krönke, Juerg Gasser

Proc Natl Acad Sci U S A· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
Florence Daubiné, Céline Le Gall, Juerg Gasser, Jonathan Green, Philippe Clézardin

J Natl Cancer Inst· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.
Teiji Wada, Tomoki Nakashima, Antonio J Oliveira-dos-Santos, Juerg Gasser, Hiromitsu Hara

Nat Med· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis